(ABCL) Abcellera Biologics - Performance -47.7% in 12m
Compare ABCL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-79.94%
#137 in Group
Rel. Strength
16.47%
#6647 in Universe
Total Return 12m
-47.66%
#86 in Group
Total Return 5y
-96.59%
#152 in Group
P/E -
(?) Percentile in Group
P/E Forward 27.5
74th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ABCL (-47.7%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ABCL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABCL
| Total Return (including Dividends) | ABCL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.15% | 11.81% | 13.81% |
| 3 Months | -33.44% | -13.61% | -6.30% |
| 12 Months | -47.66% | -12.29% | 10.65% |
| 5 Years | -96.59% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | ABCL | XBI | S&P 500 |
| 1 Month | -6.60% | 72.9% | 83% |
| 3 Months | -50.5% | -83% | -75.3% |
| 12 Months | -49.7% | -51.6% | 50.1% |
| 5 Years | -96.1% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #88 | -6.85% | -8.49% |
| 3 Month | #117 | -23.0% | -29.0% |
| 12 Month | #86 | -40.3% | -52.7% |
| 5 Years | #142 | -93.8% | -97.9% |
FAQs
Does ABCL Abcellera Biologics outperforms the market?
No,
over the last 12 months ABCL made -47.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ABCL made -33.44%, while XBI made -13.61%.
Over the last 3 months ABCL made -33.44%, while XBI made -13.61%.
Performance Comparison ABCL vs Indeces and Sectors
ABCL vs. Indices ABCL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -20.5% | -9.66% | -20.6% | -58.3% |
| US NASDAQ 100 | QQQ | -20.7% | -13.2% | -20.8% | -59.3% |
| US Dow Jones Industrial 30 | DIA | -20.9% | -5.84% | -20.3% | -55.4% |
| German DAX 40 | DAX | -20.4% | -10.8% | -46.9% | -73.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -22.6% | -7.68% | -21.4% | -55.0% |
| Hongkong Hang Seng | HSI | -23.6% | -15.8% | -29.0% | -61.3% |
| India NIFTY 50 | INDA | -15.5% | -0.69% | -21.1% | -47.5% |
| Brasil Bovespa | EWZ | -21.5% | -13.1% | -29.3% | -39.3% |
ABCL vs. Sectors ABCL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -21.1% | -9.26% | -27.7% | -69.2% |
| Consumer Discretionary | XLY | -20.8% | -10.1% | -19.6% | -61.9% |
| Consumer Staples | XLP | -19.6% | -2.44% | -27.6% | -56.8% |
| Energy | XLE | -20.3% | -2.61% | -14.0% | -38.2% |
| Financial | XLF | -21.6% | -9.37% | -27.7% | -70.1% |
| Health Care | XLV | -17.5% | 3.28% | -15.6% | -43.6% |
| Industrial | XLI | -22.2% | -12.7% | -22.1% | -58.7% |
| Materials | XLB | -20.3% | -9.41% | -15.7% | -42.4% |
| Real Estate | XLRE | -19.1% | -7.39% | -21.4% | -63.1% |
| Technology | XLK | -21.5% | -17.1% | -17.7% | -54.8% |
| Utilities | XLU | -20.5% | -5.44% | -28.3% | -65.1% |
| Aerospace & Defense | XAR | -22.4% | -17.0% | -32.1% | -75.0% |
| Biotech | XBI | -13.9% | -7.66% | -0.48% | -35.4% |
| Homebuilder | XHB | -20.9% | -7.33% | -7.43% | -40.1% |
| Retail | XRT | -22.4% | -10.5% | -16.4% | -46.2% |